BioInvent International AB (publ) Key Executives

This section highlights BioInvent International AB (publ)'s key executives, including their titles and compensation details.

Unlock Executive Information

Upgrade to access executive details

Upgrade Now

Find Contacts at BioInvent International AB (publ)

(Showing 0 of )

Unlock Team Information

Upgrade to access team member details

Upgrade Now

BioInvent International AB (publ) Earnings

This section highlights BioInvent International AB (publ)'s earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: April 22, 2025
Time: Before Market
Est. EPS: $-
Status: Unconfirmed

Last Earnings Results

Date: February 27, 2025
EPS: $-1.78
Est. EPS: $-
Revenue: $21.37M

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS

BioInvent International AB (publ) (BINV.ST)

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated myeloid cells; partnership and collaboration with Transgene to co-develskylinop multi-functional oncolytic viruses for treatment of solid tumors; and collaboration and supply agreement with Merck for the clinical development of BI-1808. The Company was incorporated in 1996 and is based in Lund, Sweden.

Healthcare Biotechnology

$31.65

Stock Price

$2.08B

Market Cap

-

Employees

Lund, None

Location

Financial Statements

Access annual & quarterly financial statements for BioInvent International AB (publ), including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $44.69M $71.46M $326.13M $19.38M $147.37M
Cost of Revenue $- $- $- $- $-
Gross Profit $44.69M $71.46M $326.13M $19.38M $147.37M
Gross Profit Ratio 100.00% 100.00% 100.00% 100.00% 100.00%
Research and Development Expenses $457.73M $390.43M $325.93M $258.34M $191.42M
General and Administrative Expenses $58.30M $51.61M $50.75M $39.44M $32.16M
Selling and Marketing Expenses $- $- $- $- $31.64M
Selling General and Administrative Expenses $58.30M $51.61M $50.75M $39.44M $31.64M
Other Expenses $-290.00K $-637.00K $-81.00K $-226.00K $-731.00K
Operating Expenses $515.75M $441.40M $376.60M $297.55M $222.33M
Cost and Expenses $515.75M $441.40M $376.60M $297.55M $222.33M
Interest Income $- $40.60M $9.07M $264.00K $28.00K
Interest Expense $- $638.00K $650.00K $517.00K $336.00K
Depreciation and Amortization $19.30M $16.75M $14.72M $14.61M $12.00M
EBITDA $-451.76M $-312.71M $-27.13M $-263.32M $-63.99M
EBITDA Ratio -1010.96% -437.59% -8.32% -1358.42% -43.42%
Operating Income $-471.06M $-369.94M $-50.92M $-278.35M $-75.47M
Operating Income Ratio -1054.15% -517.68% -15.61% -1435.98% -51.21%
Total Other Income Expenses Net $41.82M $39.84M $8.42M $-94.00K $-859.00K
Income Before Tax $-429.24M $-330.10M $-42.50M $-278.44M $-76.33M
Income Before Tax Ratio -960.57% -461.93% -13.03% -1436.46% -51.80%
Income Tax Expense $135.00K $204.00K $-8.42M $517.00K $336.00K
Net Income $-429.38M $-330.30M $-34.09M $-278.96M $-76.67M
Net Income Ratio -960.87% -462.22% -10.45% -1439.13% -52.02%
EPS $-6.54 $-5.02 $-0.55 $-5.15 $-2.67
EPS Diluted $-6.54 $-5.02 $-0.55 $-5.15 $-2.67
Weighted Average Shares Outstanding 65.68M 65.80M 61.52M 54.16M 28.72M
Weighted Average Shares Outstanding Diluted 65.68M 65.80M 61.52M 54.16M 28.72M
SEC Filing Source Source Source Source Source


Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $21.37M $12.76M $4.61M $5.94M $15.32M $26.80M $13.10M $16.25M $20.64M $17.92M $270.91M $16.66M $4.90M $2.99M $5.29M $6.20M $98.74M $16.27M $15.65M $16.71M
Cost of Revenue $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Gross Profit $21.37M $12.76M $4.61M $5.94M $15.32M $26.80M $13.10M $16.25M $20.64M $17.92M $270.91M $16.66M $4.90M $2.99M $5.29M $6.20M $98.74M $16.27M $15.65M $16.71M
Gross Profit Ratio 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Research and Development Expenses $129.29M $107.47M $138.59M $82.38M $111.60M $96.88M $97.65M $84.46M $84.98M $77.67M $91.40M $71.87M $70.45M $57.64M $53.67M $76.58M $60.08M $41.30M $47.62M $42.43M
General and Administrative Expenses $17.70M $12.82M $14.48M $13.30M $15.10M $11.28M $12.78M $12.42M $15.23M $10.43M $11.92M $13.17M $11.96M $7.82M $10.19M $9.47M $- $7.47M $7.43M $7.80M
Selling and Marketing Expenses $- $- $-4.88M $-4.71M $-4.52M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $17.70M $12.82M $9.60M $8.59M $10.58M $11.28M $12.78M $12.42M $15.23M $10.43M $11.92M $13.17M $11.96M $7.82M $10.19M $9.47M $8.94M $7.47M $7.43M $7.80M
Other Expenses $251.00K $-375.00K $-141.00K $- $- $- $- $310.00K $-757.00K $-1.03M $1.80M $-91.00K $1.16M $-38.00K $-1.46M $117.00K $-199.00K $317.00K $-305.00K $-544.00K
Operating Expenses $147.24M $119.91M $148.19M $90.97M $122.17M $108.28M $109.85M $97.19M $99.45M $87.07M $105.12M $84.95M $83.56M $65.42M $62.40M $86.17M $68.82M $49.08M $54.75M $49.69M
Cost and Expenses $147.24M $119.91M $153.07M $95.69M $126.73M $108.28M $109.85M $97.19M $99.45M $87.07M $105.12M $84.95M $83.56M $65.42M $62.40M $86.17M $68.82M $49.08M $54.75M $49.69M
Interest Income $- $9.93M $- $11.80M $13.97M $10.25M $8.40M $- $- $- $- $- $- $- $- $- $- $- $- $-
Interest Expense $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Depreciation and Amortization $4.88M $4.83M $4.88M $4.71M $4.56M $4.24M $4.10M $3.86M $4.02M $3.65M $3.58M $3.48M $3.68M $3.88M $3.57M $3.48M $3.11M $3.07M $3.00M $2.83M
EBITDA $-121.00M $-102.31M $-143.44M $-85.01M $-92.39M $-77.08M $-92.66M $-77.08M $-74.32M $-65.51M $169.37M $-64.81M $-74.74M $-58.55M $-53.54M $-76.49M $33.03M $-29.74M $-36.10M $-30.14M
EBITDA Ratio -566.23% -801.58% -3113.88% -1431.05% -697.53% -327.06% -771.74% -518.73% -320.62% -395.03% 61.90% -392.30% -1524.39% -1950.35% -1008.96% -1236.56% 32.40% -182.44% -229.20% -182.32%
Operating Income $-125.87M $-107.15M $-148.46M $-89.74M $-111.41M $-81.48M $-96.75M $-80.94M $-79.26M $-69.15M $165.55M $-68.29M $-78.85M $-62.43M $-57.11M $-79.97M $29.41M $-32.81M $-39.10M $-32.97M
Operating Income Ratio -589.04% -839.44% -3219.74% -1510.33% -727.29% -304.06% -738.85% -498.12% -384.03% -385.89% 61.11% -409.92% -1608.14% -2085.87% -1079.95% -1289.76% 29.78% -201.72% -249.86% -197.27%
Total Other Income Expenses Net $9.04M $9.93M $11.04M $11.80M $13.97M $10.25M $8.40M $7.21M $928.00K $5.52M $1.90M $540.00K $87.00K $-175.00K $-183.00K $177.00K $-888.00K $-63.00K $-237.00K $329.00K
Income Before Tax $-116.83M $-97.21M $-137.28M $-77.92M $-96.95M $-71.08M $-88.35M $-73.73M $-78.33M $-63.87M $167.45M $-67.75M $-78.76M $-62.60M $-57.29M $-79.79M $28.52M $-32.88M $-39.34M $-32.64M
Income Before Tax Ratio -546.74% -761.63% -2977.21% -1311.26% -632.91% -265.26% -674.66% -453.74% -379.53% -356.41% 61.81% -406.68% -1606.36% -2091.71% -1083.42% -1286.90% 28.88% -202.10% -251.37% -195.30%
Income Tax Expense $48.00K $28.00K $28.00K $31.00K $204.00K $-10.40M $-8.40M $-14.42M $8.14M $-5.28M $-1.90M $-540.00K $423.00K $175.00K $183.00K $-177.00K $-1.04M $63.00K $237.00K $-329.00K
Net Income $-116.88M $-97.24M $-137.31M $-77.95M $-97.16M $-71.08M $-88.35M $-59.31M $-86.47M $-58.58M $167.45M $-67.21M $-78.76M $-62.60M $-57.29M $-79.79M $28.52M $-32.88M $-39.34M $-32.64M
Net Income Ratio -546.96% -761.85% -2977.81% -1311.78% -634.24% -265.26% -674.66% -364.97% -418.97% -326.92% 61.81% -403.43% -1606.36% -2091.71% -1083.42% -1286.90% 28.88% -202.10% -251.37% -195.30%
EPS $-1.78 $-1.48 $-2.09 $-1.18 $-1.48 $-1.08 $-1.34 $-0.90 $-1.33 $-0.92 $2.86 $-1.15 $-1.45 $-1.07 $-0.98 $-1.94 $0.87 $-1.00 $-2.00 $-1.63
EPS Diluted $-1.78 $-1.48 $-2.09 $-1.18 $-1.48 $-1.08 $-1.34 $-0.90 $-1.33 $-0.92 $2.86 $-1.15 $-1.45 $-1.07 $-0.98 $-1.94 $0.87 $-1.00 $-2.00 $-1.63
Weighted Average Shares Outstanding 65.66M 65.70M 65.80M 65.80M 65.80M 65.80M 65.80M 65.80M 64.97M 63.87M 58.47M 58.40M 54.16M 58.47M 58.46M 41.13M 32.88M 32.88M 19.67M 20.03M
Weighted Average Shares Outstanding Diluted 65.66M 65.70M 65.80M 65.80M 65.80M 65.80M 65.80M 65.80M 64.97M 63.87M 58.55M 58.40M 54.16M 58.51M 58.46M 41.13M 32.88M 32.88M 19.67M 20.03M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents $434.83M $259.55M $515.05M $910.75M $729.27M
Short Term Investments $432.33M $809.15M $502.43M $172.07M $-
Cash and Short Term Investments $867.16M $1.07B $1.02B $1.08B $729.27M
Net Receivables $- $11.93M $36.58M $370.00K $29.92M
Inventory $10.97M $11.84M $11.51M $16.85M $4.08M
Other Current Assets $65.09M $40.79M $42.69M $15.97M $9.78M
Total Current Assets $943.21M $1.13B $1.08B $1.12B $773.04M
Property Plant Equipment Net $46.02M $52.66M $52.01M $49.08M $29.60M
Goodwill $- $- $- $- $-
Intangible Assets $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $-
Long Term Investments $- $-594.90M $73.71M $110.13M $580.00K
Tax Assets $- $- $- $- $-
Other Non-Current Assets $- $809.15M $502.43M $172.07M $-580.00K
Total Non-Current Assets $46.02M $266.92M $628.15M $331.29M $29.60M
Other Assets $- $- $- $- $-
Total Assets $989.24M $1.40B $1.71B $1.45B $802.64M
Account Payables $- $29.19M $41.35M $19.72M $16.91M
Short Term Debt $9.20M $8.71M $8.19M $-16.37M $-16.64M
Tax Payables $- $- $- $- $-
Deferred Revenue $- $- $- $23.20M $22.61M
Other Current Liabilities $86.01M $38.02M $37.78M $9.04M $8.02M
Total Current Liabilities $95.21M $75.92M $87.32M $58.79M $53.51M
Long Term Debt $8.21M $14.54M $18.77M $21.53M $5.63M
Deferred Revenue Non-Current $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $- $-
Total Non-Current Liabilities $8.21M $14.54M $18.77M $21.53M $5.63M
Other Liabilities $- $- $- $- $-
Total Liabilities $103.42M $90.45M $106.09M $80.32M $59.14M
Preferred Stock $- $- $- $- $-
Common Stock $- $13.16M $12.99M $11.69M $78.75M
Retained Earnings $- $-2.46B $-2.14B $-2.09B $-1.82B
Accumulated Other Comprehensive Income Loss $- $1.00K $1.00K $1.00K $1.00K
Other Total Stockholders Equity $885.82M $3.76B $3.73B $3.45B $2.48B
Total Stockholders Equity $885.82M $1.31B $1.61B $1.37B $743.50M
Total Equity $885.82M $1.31B $1.61B $1.37B $743.50M
Total Liabilities and Stockholders Equity $989.24M $1.40B $1.71B $1.45B $802.64M
Minority Interest $- $- $- $- $-
Total Liabilities and Total Equity $989.24M $1.40B $1.71B $1.45B $802.64M
Total Investments $432.33M $214.25M $576.14M $282.21M $580.00K
Total Debt $17.41M $23.24M $26.96M $28.37M $11.60M
Net Debt $-417.41M $-236.30M $-488.08M $-882.39M $-717.67M


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $434.83M $717.36M $470.25M $469.14M $259.55M $589.79M $570.57M $542.52M $515.05M $696.32M $591.22M $769.79M $910.75M $1.26B $1.51B $1.58B $729.27M $642.10M $182.28M $117.13M
Short Term Investments $432.33M $232.75M $591.25M $594.96M $809.15M $563.95M $530.60M $475.96M $502.43M $527.05M $386.81M $236.95M $172.07M $6.00M $- $- $- $- $- $-
Cash and Short Term Investments $867.16M $950.11M $1.06B $1.06B $1.07B $1.15B $1.10B $1.02B $1.02B $1.22B $978.04M $1.01B $1.08B $1.26B $1.51B $1.58B $729.27M $642.10M $182.28M $117.13M
Net Receivables $- $50.98M $47.95M $50.26M $32.66M $61.84M $74.48M $44.69M $36.58M $34.95M $283.02M $38.00M $16.34M $10.08M $16.03M $14.39M $29.92M $28.04M $32.39M $40.20M
Inventory $10.97M $9.89M $10.52M $8.98M $11.84M $13.31M $10.75M $14.12M $11.51M $11.24M $12.17M $13.48M $16.85M $13.13M $12.45M $6.89M $4.08M $4.21M $5.57M $5.81M
Other Current Assets $65.09M $- $1 $- $40.79M $- $- $- $42.69M $- $- $- $15.97M $- $- $- $9.78M $- $- $-
Total Current Assets $943.21M $1.01B $1.12B $1.12B $1.13B $1.23B $1.19B $1.08B $1.08B $1.27B $1.27B $1.06B $1.12B $1.28B $1.54B $1.60B $773.04M $674.35M $220.25M $163.14M
Property Plant Equipment Net $46.02M $47.42M $50.28M $50.24M $52.66M $50.37M $51.85M $51.27M $52.01M $44.58M $46.97M $48.40M $49.08M $51.65M $50.06M $28.15M $29.60M $29.19M $30.57M $31.19M
Goodwill $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Long Term Investments $- $29.07M $28.75M $155.05M $214.25M $-360.18M $-170.11M $51.95M $73.71M $-86.08M $-150.27M $37.17M $110.13M $188.80M $- $- $- $- $- $-
Tax Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non-Current Assets $- $- $-1 $-1 $-1 $563.95M $530.60M $475.96M $502.43M $527.05M $386.81M $236.95M $172.07M $- $- $- $- $- $- $-
Total Non-Current Assets $46.02M $76.49M $79.02M $205.29M $266.91M $254.14M $412.34M $579.18M $628.15M $485.55M $283.51M $322.52M $331.29M $240.45M $50.06M $28.15M $29.60M $29.19M $30.57M $31.19M
Other Assets $- $- $1 $1 $1 $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $989.24M $1.09B $1.20B $1.33B $1.40B $1.48B $1.60B $1.66B $1.71B $1.76B $1.56B $1.38B $1.45B $1.52B $1.59B $1.63B $802.64M $703.54M $250.82M $194.34M
Account Payables $- $67.36M $82.37M $74.81M $29.19M $55.58M $99.27M $67.56M $41.35M $47.26M $64.18M $54.68M $19.72M $44.74M $48.76M $51.12M $16.91M $- $- $-
Short Term Debt $9.20M $8.71M $8.71M $8.71M $8.71M $7.74M $7.97M $8.19M $8.19M $6.52M $6.63M $6.73M $-48.60M $6.94M $6.18M $6.18M $-47.26M $6.06M $6.06M $6.06M
Tax Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Revenue $- $- $-82.37M $-74.81M $-5.77M $-55.58M $-99.27M $-67.56M $- $-47.26M $-64.18M $-54.68M $23.20M $-44.74M $-48.76M $-51.12M $22.61M $- $- $-
Other Current Liabilities $86.01M $- $- $- $38.02M $- $- $- $37.78M $- $- $- $9.04M $- $- $- $8.02M $38.56M $44.77M $43.79M
Total Current Liabilities $95.21M $76.06M $91.08M $83.52M $75.92M $63.32M $107.24M $75.75M $87.32M $53.78M $70.81M $61.41M $58.79M $51.68M $54.95M $57.31M $53.51M $44.62M $50.82M $49.85M
Long Term Debt $8.21M $8.31M $10.40M $12.47M $14.54M $13.46M $15.17M $16.86M $18.77M $17.06M $18.56M $20.05M $21.53M $23.00M $25.14M $3.98M $5.63M $5.12M $6.58M $8.03M
Deferred Revenue Non-Current $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Non-Current Liabilities $8.21M $8.31M $10.40M $12.47M $14.53M $13.46M $15.17M $16.86M $18.77M $17.06M $18.56M $20.05M $21.53M $23.00M $25.14M $3.98M $5.63M $5.12M $6.58M $8.03M
Other Liabilities $- $- $- $1 $1 $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $103.42M $84.38M $101.48M $95.99M $90.45M $76.77M $122.41M $92.61M $106.09M $70.84M $89.37M $81.46M $80.32M $74.69M $80.08M $61.29M $59.14M $49.74M $57.40M $57.88M
Preferred Stock $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $- $13.20M $13.20M $13.20M $13.16M $13.20M $13.20M $13.20M $12.99M $13.00M $11.70M $11.70M $11.69M $11.70M $11.70M $11.70M $78.75M $653.80M $193.42M $136.46M
Retained Earnings $- $- $- $- $-2.46B $- $- $- $-2.14B $- $- $- $-2.09B $- $- $- $-1.82B $- $- $-
Accumulated Other Comprehensive Income Loss $- $- $1.08B $1.22B $1.00K $1.39B $1.46B $1.55B $1.00K $- $- $1.29B $1.00K $- $- $- $1,000 $- $- $-
Other Total Stockholders Equity $885.82M $989.89M $1.08B $1.22B $3.76B $1.39B $1.46B $1.55B $3.73B $- $- $1.29B $3.45B $- $- $- $2.48B $- $- $-
Total Stockholders Equity $885.82M $1.00B $1.10B $1.23B $1.31B $1.41B $1.48B $1.56B $1.61B $1.68B $1.47B $1.30B $1.37B $1.45B $1.51B $1.57B $743.50M $653.80M $193.42M $136.46M
Total Equity $885.82M $1.00B $1.10B $1.23B $1.31B $1.41B $1.48B $1.56B $1.61B $1.68B $1.47B $1.30B $1.37B $1.45B $1.51B $1.57B $743.50M $653.80M $193.42M $136.46M
Total Liabilities and Stockholders Equity $989.24M $1.09B $1.20B $1.33B $1.40B $1.48B $1.60B $1.66B $1.71B $1.76B $1.56B $1.38B $1.45B $1.52B $1.59B $1.63B $802.64M $703.54M $250.82M $194.34M
Minority Interest $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities and Total Equity $989.24M $1.09B $1.20B $1.33B $1.40B $1.48B $1.60B $1.66B $1.71B $1.76B $1.56B $1.38B $1.45B $1.52B $1.59B $1.63B $802.64M $703.54M $250.82M $194.34M
Total Investments $432.33M $261.82M $620.00M $750.01M $214.25M $203.78M $360.49M $527.90M $576.14M $440.97M $236.54M $274.12M $282.21M $188.80M $- $- $- $- $- $-
Total Debt $17.41M $17.02M $19.11M $21.18M $23.24M $21.20M $23.13M $25.05M $26.96M $23.58M $25.18M $26.78M $28.37M $29.94M $31.32M $10.17M $11.60M $11.18M $12.64M $14.09M
Net Debt $-417.41M $-700.34M $-451.14M $-447.96M $-236.30M $-568.60M $-547.43M $-517.46M $-488.08M $-672.74M $-566.04M $-743.01M $-882.39M $-1.23B $-1.48B $-1.57B $-717.67M $-630.92M $-169.65M $-103.04M

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $-471.06M $-330.30M $-50.92M $-278.35M $-75.47M
Depreciation and Amortization $19.30M $16.75M $14.72M $14.61M $12.00M
Deferred Income Tax $- $-36.46M $-1.79M $-1.14M $41.00K
Stock Based Compensation $5.46M $2.95M $1.79M $1.14M $-41.00K
Change in Working Capital $7.57M $-10.14M $-6.78M $17.03M $1.20M
Accounts Receivables $- $2.35M $-38.73M $23.35M $-5.94M
Inventory $- $-338.00K $5.34M $-12.77M $1.30M
Accounts Payables $- $-12.16M $26.62M $6.44M $5.84M
Other Working Capital $7.57M $- $26.62M $6.44M $5.84M
Other Non Cash Items $58.26M $15.51M $1.75M $869.00K $-348.00K
Net Cash Provided by Operating Activities $-380.47M $-341.69M $-41.23M $-245.84M $-62.62M
Investments in Property Plant and Equipment $-10.03M $-13.30M $-12.38M $-13.26M $-6.70M
Acquisitions Net $- $- $- $- $-
Purchases of Investments $- $- $-616.47M $-454.28M $-
Sales Maturities of Investments $- $72.98M $- $- $-
Other Investing Activities $574.38M $- $-616.47M $-454.28M $-
Net Cash Used for Investing Activities $564.35M $59.68M $-628.85M $-467.54M $-6.70M
Debt Repayment $- $- $- $- $-
Common Stock Issued $- $30.96M $279.85M $900.79M $650.44M
Common Stock Repurchased $- $- $- $- $-
Dividends Paid $- $- $- $- $-
Other Financing Activities $-8.46M $-7.82M $-6.36M $-5.92M $-5.82M
Net Cash Used Provided by Financing Activities $-8.46M $23.14M $273.49M $894.87M $644.62M
Effect of Forex Changes on Cash $- $3.37M $880.00K $- $-
Net Change in Cash $175.28M $-255.50M $-395.71M $181.49M $575.29M
Cash at End of Period $434.83M $259.55M $515.05M $910.75M $729.27M
Cash at Beginning of Period $259.55M $515.05M $910.75M $729.27M $153.97M
Operating Cash Flow $-380.47M $-341.69M $-41.23M $-245.84M $-62.62M
Capital Expenditure $-10.03M $-13.30M $-12.38M $-13.26M $-6.70M
Free Cash Flow $-390.50M $-355.00M $-53.60M $-259.10M $-69.32M

Cash Flow Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Net Income $-125.87M $-97.24M $-137.31M $-77.95M $-97.16M $-81.32M $-96.75M $-80.94M $-79.26M $-69.15M $165.78M $-68.29M $-78.85M $-62.43M $-57.11M $-79.97M $29.41M $-32.81M $-39.10M $-32.97M
Depreciation and Amortization $4.88M $4.83M $4.88M $4.71M $4.56M $4.24M $4.10M $3.86M $4.02M $3.65M $3.58M $3.48M $3.68M $3.88M $3.57M $3.48M $3.11M $3.07M $3.00M $2.83M
Deferred Income Tax $- $- $- $- $-9.74M $- $-831.00K $-496.00K $-198.00K $-904.00K $-639.00K $- $- $- $- $- $- $- $- $-
Stock Based Compensation $-398.00K $- $2.19M $856.00K $617.00K $1.01M $831.00K $496.00K $198.00K $904.00K $639.00K $48.00K $252.00K $-18.00K $186.00K $718.00K $125.00K $96.00K $76.00K $-338.00K
Change in Working Capital $3.60M $-17.51M $8.38M $13.10M $22.35M $-33.75M $5.02M $-3.77M $2.99M $237.49M $-232.40M $-14.86M $-711.00K $1.09M $-9.67M $26.32M $-3.34M $-1.70M $10.04M $-3.81M
Accounts Receivables $- $- $- $- $2.35M $- $- $- $-38.73M $- $- $- $23.35M $- $- $- $-5.94M $- $- $-
Inventory $- $- $- $- $-338.00K $- $- $- $5.34M $- $- $- $-12.77M $- $- $- $1.30M $- $- $-
Accounts Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Working Capital $3.60M $-17.51M $8.38M $13.10M $20.34M $-33.75M $5.02M $-3.77M $36.38M $237.49M $-232.40M $-14.86M $-11.29M $1.09M $-9.67M $26.32M $1.31M $-1.70M $10.04M $-3.81M
Other Non Cash Items $19.48M $12.87M $14.60M $3.66M $6.98M $3.58M $3.50M $1.92M $590.00K $783.00K $500.00K $-128.00K $137.00K $-36.00K $122.00K $646.00K $20.00K $80.00K $-13.00K $-435.00K
Net Cash Provided by Operating Activities $-98.31M $-97.05M $-119.21M $-65.90M $-72.39M $-106.24M $-84.13M $-78.92M $-71.67M $172.77M $-62.54M $-79.80M $-75.74M $-57.49M $-63.09M $-49.52M $29.20M $-31.36M $-26.08M $-34.39M
Investments in Property Plant and Equipment $-849.00K $-1.98M $-4.92M $-2.28M $-2.75M $-2.75M $-4.68M $-3.12M $-6.18M $-1.25M $-2.15M $-2.79M $-2.97M $-5.47M $-2.82M $-2.00M $-1.61M $-1.70M $-2.37M $-1.02M
Acquisitions Net $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Purchases of Investments $- $- $- $- $- $- $- $- $-102.73M $-344.67M $-112.28M $-56.79M $-265.48M $-188.80M $- $- $- $- $- $-
Sales Maturities of Investments $- $- $121.34M $272.52M $-250.89M $126.61M $118.96M $78.31M $- $- $- $- $- $- $- $- $- $- $- $-
Other Investing Activities $-170.46M $350.97M $121.34M $272.52M $-250.89M $126.61M $118.96M $78.31M $-102.73M $-344.67M $-112.28M $-56.79M $-265.48M $-188.80M $- $- $- $- $- $-
Net Cash Used for Investing Activities $-171.30M $349.00M $116.42M $270.24M $-253.65M $123.86M $114.29M $75.18M $-108.91M $-345.92M $-114.44M $-59.58M $-268.45M $-194.28M $-2.82M $-2.00M $-1.61M $-1.70M $-2.37M $-1.02M
Debt Repayment $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock Issued $- $- $- $- $- $- $- $30.96M $- $279.85M $- $- $- $- $- $900.79M $61.05M $494.33M $95.06M $-
Common Stock Repurchased $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Dividends Paid $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Financing Activities $-2.23M $-2.09M $-2.07M $-2.06M $-2.06M $-1.93M $-1.92M $-1.91M $-1.57M $-1.61M $-1.60M $-1.59M $-1.58M $-1.38M $-1.51M $-1.47M $-1.47M $-1.46M $-1.45M $-1.44M
Net Cash Used Provided by Financing Activities $-2.23M $-2.09M $-2.07M $-2.06M $-2.06M $-1.93M $-1.92M $29.05M $-1.57M $278.24M $-1.60M $-1.59M $-1.58M $-1.38M $-1.51M $899.33M $59.59M $492.87M $93.61M $-1.44M
Effect of Forex Changes on Cash $- $- $- $- $-2.15M $3.55M $-182.00K $2.16M $880.00K $- $- $- $- $- $- $- $- $- $- $-
Net Change in Cash $-282.54M $247.11M $1.11M $209.59M $-330.25M $19.23M $28.05M $27.47M $-181.27M $105.09M $-178.57M $-140.96M $-345.76M $-253.15M $-67.42M $847.81M $87.17M $459.81M $65.16M $-36.85M
Cash at End of Period $434.83M $717.36M $470.25M $469.14M $259.55M $589.79M $570.57M $542.52M $515.05M $696.32M $591.22M $769.79M $910.75M $1.26B $1.51B $1.58B $729.27M $642.10M $182.28M $117.13M
Cash at Beginning of Period $717.36M $470.25M $469.14M $259.55M $589.79M $570.57M $542.52M $515.05M $696.32M $591.22M $769.79M $910.75M $1.26B $1.51B $1.58B $729.27M $642.10M $182.28M $117.13M $153.97M
Operating Cash Flow $-98.31M $-97.05M $-119.21M $-65.90M $-72.39M $-106.24M $-84.13M $-78.92M $-71.67M $172.77M $-62.54M $-79.80M $-75.74M $-57.49M $-63.09M $-49.52M $29.20M $-31.36M $-26.08M $-34.39M
Capital Expenditure $-849.00K $-1.98M $-4.92M $-2.28M $-2.75M $-2.75M $-4.68M $-3.12M $-6.18M $-1.25M $-2.15M $-2.79M $-2.97M $-5.47M $-2.82M $-2.00M $-1.61M $-1.70M $-2.37M $-1.02M
Free Cash Flow $-99.16M $-99.03M $-124.13M $-68.18M $-75.14M $-108.99M $-88.81M $-82.05M $-77.84M $171.52M $-64.69M $-82.59M $-78.70M $-62.97M $-65.91M $-51.52M $27.59M $-33.05M $-28.45M $-35.41M

BioInvent International AB (publ) Dividends

Explore BioInvent International AB (publ)'s dividend history, including dividend yield, payout ratio, and historical payments.

BioInvent International AB (publ) does not currently pay a dividend.

BioInvent International AB (publ) News

Read the latest news about BioInvent International AB (publ), including recent articles, headlines, and updates.

Similar Companies

A
Active Biotech AB (publ)

ACTI.ST

Price: $0.09

Market Cap: $113.42M

C
Cantargia AB (publ)

CANTA.ST

Price: $1.51

Market Cap: $375.40M

H
Hansa Biopharma AB (publ)

HNSA.ST

Price: $23.60

Market Cap: $1.60B

O
Oncopeptides AB (publ)

ONCO.ST

Price: $1.50

Market Cap: $311.84M

S
Saniona AB (publ)

SANION.ST

Price: $6.36

Market Cap: $715.71M

Related Metrics

Explore detailed financial metrics and analysis for BINV.ST.